KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
77 hedge funds and large institutions have $366M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
–
Holders Change %
0%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
16
Reduced
26
Closed
8
Calls
–
Puts
$1M
Net Calls
-$1M
Net Calls Change
-$402K
Top Buyers
| 1 |
Millennium Management
New York
|
+$4.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.24M |
| 3 |
AA
ALPS Advisors
Denver,
Colorado
|
+$735K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$557K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$522K |
Top Sellers
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$4.33M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$3.17M |
| 3 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$2.44M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.55M |
| 5 |
Renaissance Technologies
New York
|
-$1.46M |
